CNCE

Concert Pharmaceuticals, Inc. News Headlines

$13.21
*  
0.68
4.9%
Get CNCE Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading CNCE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CNCE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
JAZZ Pharmaceuticals Slips After Dosing Issue on JZP-386 - Analyst Blog
12/10/2014 2:39:00 PM - Zacks.com


InsiderInsights.com Daily Round Up 11/20/14: NES, OPK, OKS, PAH
11/24/2014 3:04:00 PM - Seeking Alpha


Flamel Technologies: A Turnaround Story With Lots Of Upside
11/21/2014 1:05:00 PM - Seeking Alpha


Concert Pharma To Present At Stifel Healthcare Conference; Webcast At 1:50 PM
11/18/2014 12:50:00 PM - RTT News


Concert Pharmaceuticals Announces Positive CTP-354 Data - Analyst Blog
10/15/2014 5:04:00 PM - Zacks.com


Kidney failure biotech Proteon Therapeutics sets terms for $61 million IPO
10/7/2014 2:23:57 PM - Renaissance Capital


Kidney failure biotech Proteon Therapeutics files for a $69 million IPO
9/16/2014 3:10:44 PM - Renaissance Capital


Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% - Tale of the Tape
9/16/2014 7:57:00 AM - Zacks.com


Jazz Pharmaceuticals/Concert Pharmaceuticals Start Study - Analyst Blog
7/22/2014 4:25:00 PM - Zacks.com


Concert Pharmaceuticals' Shares Slip Despite Favorable FDA Meeting - Analyst Blog
7/9/2014 10:40:00 AM - Zacks.com


Why Concert Pharmaceuticals (CNCE) Could Shock the Market Soon - Tale of the Tape
5/13/2014 7:53:00 AM - Zacks.com


Concert's First Drug: Not So Great
4/29/2014 1:07:00 PM - Seeking Alpha


Concert Pharmaceuticals (CNCE) Catches Eye: Stock Up 9.3% - Tale of the Tape
4/1/2014 8:25:01 AM - Zacks.com


Concert Pharmaceuticals Quiet Period Expiration Could Be A Well-Orchestrated Long Opportunity For Investors
3/3/2014 10:43:00 AM - Seeking Alpha


Auspex Is A Compelling Short Idea
2/19/2014 10:14:00 AM - Seeking Alpha


US IPO Recap: Wave goodbye to the biotech wave as tech prepares to take over
2/18/2014 9:29:52 AM - Renaissance Capital


Health IPOs Down 1% And Housing IPOs Trade Up After Heavy Discount
2/14/2014 12:22:00 PM - Seeking Alpha


Concert Pharmaceuticals prices upsized IPO at $14, the high end of the range
2/13/2014 8:48:52 AM - Renaissance Capital


IPO Preview: Concert Pharmaceuticals
2/13/2014 1:00:00 AM - Seeking Alpha


Concert Pharmaceuticals IPO Sounds Good
2/12/2014 3:54:00 PM - Seeking Alpha


9 U.S. IPOs Planned For The Week Of Feb. 10
2/11/2014 7:32:00 AM - Seeking Alpha


U.S. IPO Recap: Revance Jumps 68% In 10 IPO Week
2/11/2014 7:27:00 AM - Seeking Alpha


9 US IPOs planned for the week of Feb 10
2/10/2014 8:46:18 AM - Renaissance Capital


Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha


Biotech Concert Pharmaceuticals sets terms for $75 million IPO
2/3/2014 8:02:26 AM - Renaissance Capital